Press release
Investigation announced for long-term investors in shares of Zogenix, Inc. (NASDAQ: ZGNX)
An investigation on behalf of current long term investors in Zogenix, Inc. (NASDAQ: ZGNX) shares.
Investors who are current long term investors in Zogenix, Inc. (NASDAQ: ZGNX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ZGNX stocks follows a lawsuit filed against Zogenix, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ZGNX stocks, concerns whether certain Zogenix, directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Zogenix’s NDA for FINTEPLA contained inadequate non-clinical data and an incorrect version of a clinical dataset, that consequently, Zogenix’s NDA for FINTEPLA was unlikely to gain FDA approval, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.
Those who purchased shares of Zogenix, Inc. (NASDAQ: ZGNX) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for long-term investors in shares of Zogenix, Inc. (NASDAQ: ZGNX) here
News-ID: 1829856 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders…
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) sho …
An investor, who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS), filed a lawsuit over alleged violations of Federal Securities Laws by AST SpaceMobile, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 17, 2024. NASDAQ: ASTS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDA …
An investor, who purchased shares of Sharecare, Inc. (NASDAQ: SHCR), filed a lawsuit over alleged violations of Federal Securities Laws by Sharecare, Inc.
Investors who purchased shares of Sharecare, Inc. (NASDAQ: SHCR) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2024. NASDAQ: SHCR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Atlanta, GA based Sharecare, Inc. operates as…
More Releases for Zogenix
Needle-Free Injection Device Market 2021 Clinical Survey Report - Zogenix, Inovi …
In 2020, the global Needle-Free Injection Device market size was US$ 187.8 million and it is expected to reach US$ 363.7 million by the end of 2027, with a CAGR of 9.9% during 2021-2027.
The research report studies the Needle-Free Injection Device market using different methodologies and analyzers to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects…
Needle Free Injectior Market Growth by Top Most Key Players Zogenix,Inovio,Glide …
Needle Free Injectior Market
DataIntelo, 17-03-2020: The research report on the Needle Free Injectior Market is a deep analysis of the market. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.
Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing…
Investigation announced for Investors in shares of Zogenix, Inc. (NASDAQ: ZGNX)
An investigation on behalf of current long-term investors in shares of Zogenix, Inc. (NASDAQ: ZGNX) was announced over potential breaches of fiduciary duties by certain officers and directors at Zogenix, Inc.
Investors who purchased shares of Zogenix, Inc. (NASDAQ: ZGNX) and currently hold any of those NASDAQ: ZGNX shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Musculoskeletal Pains Market 2017-2025 | Type, Growth, Drugs, Treatment, Organs, …
Global Musculoskeletal Pains Market: Snapshot
Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive use of muscle groups, improper use or accidents such as falls, etc. and can persist for a long time, causing discomfort to the patient. The consistent discomfort caused by…
Musculoskeletal Pains Market Highly Fragmented over 2025 - DURECT Corporation, Z …
Global Musculoskeletal Pains Market: Snapshot
Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive use of muscle groups, improper use or accidents such as falls, etc. and can persist for a long time, causing discomfort to the patient. The consistent discomfort caused by…
Feb 16, 2018: Subcutaneous Drug Delivery Equipment Market Share 2025 Merck, Zoge …
Subcutaneous Drug Delivery Equipment Market Research 2018
A market study "Global Subcutaneous Drug Delivery Equipment Market" examines the performance of the Subcutaneous Drug Delivery Equipment market 2018. It encloses an in-depth Research of the Subcutaneous Drug Delivery Equipment market state and the competitive landscape globally. This report analyzes the potential of Subcutaneous Drug Delivery Equipment market in the present and the future prospects from various angles in detail.
The Global Subcutaneous Drug…
